Several other research firms also recently commented on SNPS. Zacks Investment Research downgraded Synopsys from a “hold” rating to a “sell” rating and set a $143.00 target price on the stock. in a research report on Wednesday, July 24th. KeyCorp upped their target price on Synopsys from $135.00 to $152.00 and gave the company an “overweight” rating in a research report on Friday, July 12th. Wells Fargo & Co started coverage on Synopsys in a research report on Tuesday, May 14th. They issued an “outperform” rating and a $135.00 target price on the stock. Finally, Bank of America reaffirmed an “average” rating on shares of Synopsys in a research report on Wednesday, June 5th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $137.30.
Synopsys stock opened at $139.00 on Wednesday. Synopsys has a 12 month low of $79.14 and a 12 month high of $142.00. The stock’s 50 day moving average is $133.39 and its 200-day moving average is $119.39. The company has a current ratio of 0.95, a quick ratio of 0.85 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $19.48 billion, a price-to-earnings ratio of 49.29, a PEG ratio of 3.90 and a beta of 1.27.
Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, August 21st. The semiconductor company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.62 by $0.03. Synopsys had a return on equity of 16.88% and a net margin of 18.74%. The company had revenue of $853.00 million for the quarter, compared to the consensus estimate of $831.03 million. During the same quarter in the prior year, the business earned $0.95 earnings per share. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. As a group, equities research analysts predict that Synopsys will post 3.03 earnings per share for the current fiscal year.
In related news, Director Roy Vallee sold 15,596 shares of the stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $128.95, for a total transaction of $2,011,104.20. Following the sale, the director now owns 52,641 shares of the company’s stock, valued at $6,788,056.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Steven Walske sold 2,453 shares of the stock in a transaction that occurred on Friday, June 28th. The stock was sold at an average price of $126.54, for a total value of $310,402.62. Following the sale, the director now directly owns 14,038 shares in the company, valued at approximately $1,776,368.52. The disclosure for this sale can be found here. Insiders have sold 34,925 shares of company stock worth $4,471,565 in the last three months. 1.84% of the stock is currently owned by company insiders.
A number of large investors have recently modified their holdings of SNPS. Geode Capital Management LLC grew its stake in Synopsys by 5.1% during the 4th quarter. Geode Capital Management LLC now owns 2,244,335 shares of the semiconductor company’s stock worth $188,775,000 after buying an additional 109,140 shares during the last quarter. Strs Ohio grew its stake in Synopsys by 141.2% during the 1st quarter. Strs Ohio now owns 67,883 shares of the semiconductor company’s stock worth $7,816,000 after buying an additional 39,743 shares during the last quarter. Conning Inc. bought a new position in Synopsys during the 1st quarter worth $260,000. Smith Graham & Co. Investment Advisors LP grew its stake in Synopsys by 1.0% during the 1st quarter. Smith Graham & Co. Investment Advisors LP now owns 50,189 shares of the semiconductor company’s stock worth $5,779,000 after buying an additional 520 shares during the last quarter. Finally, Graybill Bartz & Assoc Ltd. grew its stake in Synopsys by 1.0% during the 1st quarter. Graybill Bartz & Assoc Ltd. now owns 25,781 shares of the semiconductor company’s stock worth $2,969,000 after buying an additional 250 shares during the last quarter. 90.58% of the stock is currently owned by institutional investors and hedge funds.
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also: What is Compound Interest?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.